Clinical Development of Biosimilars

Clinical trials which includes the preclinical, Phase I, Phase II, and Phase III trial stages. Clinical trials are designed in stages I-IV so as to receive a clear picture of the drug candidate in respect to its pharmacokinetics and pharmacodynamics parameters.some Factors are considered in clinical development include analytical methods design, study population,sample size, duration .This track includes Genotoxicity,Transgenic animals,Targeted cell line development Clinical PK/PD studies,Transgenic animals.

  • Clinical PK/PD studies
  • Biosimilars Clinical Studies
  • Genotoxicity tests
  • Poisonousness studies
  • Targeted cell line development
  • Clinical trials on major diseases
  • Transgenic animals
  • Female Reproductive Endocrinology

Related Conference of Clinical Development of Biosimilars

August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
August 29-30, 2018 |

International Conference and Exhibition on Drug Safety & Pharmacovigilance

Park Inn By Radisson, Toronto, Canada
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 14-15, 2018

13th International Conference on Biosimilars and Biologics

Lisbon, Portugal
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Clinical Development of Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in